MODD — Modular Medical Income Statement
0.000.00%
Last trade - 00:00- $31.92m
- $24.40m
Annual income statement for Modular Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7.34 | 16.2 | 13.9 | 17.5 | 19 |
| Operating Profit | -7.34 | -16.2 | -13.9 | -17.5 | -19 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.38 | -18.6 | -13.9 | -17.5 | -18.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.38 | -18.6 | -13.9 | -17.5 | -18.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.38 | -18.6 | -13.9 | -17.5 | -18.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.38 | -18.6 | -13.9 | -17.5 | -18.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.19 | -2.61 | -1.28 | -0.781 | -0.509 |